Boccalatte Luis A, Gómez Natalia L, Olivera López Soledad, Yanzon Alejandro, Abuawad Carla Y, Smith David E, Mazzaro Eduardo L, Figari Marcelo F
Cirugía de cabeza y cuello, Servicio de Cirugía General, Hospital Italiano de Buenos Aires, Argentina. E-mail:
Departamento Académico de Ciencias Morfológicas, Instituto Universitario, Hospital Italiano de Buenos Aires, Argentina.
Medicina (B Aires). 2020;80(1):39-47.
The ectopic parathyroid tissue is a frequent cause of recurrent hyperparathyroidism (HPT), accounting 16% in primary HPT and 14% in secondary cases. Although intrathoracic ectopic glands represent 25-35% of all ectopic cases, only 2% requires thoracic surgery. The aim of this study is to report a case series of patients with ectopic mediastinal HPT treated by thoracic approach in a private institution in Argentina. This is a retrospective analysis from January 2006 to June 2019. All patients diagnosed with ectopic hyperparathyroidism who required a thoracic surgical approach were included. During this period, 728 patients with primary HPT and secondary HPT were treated. Six with primary HPT and 3 with secondary HPT required a thoracic approach. Six video-assisted thoracoscopy surgeries (VATS) and 3 sternotomies were performed. None of them presented serious posoperative complications. Frozen section biopsy was used in all cases. iPTH was measured in 8 cases, with a mean drop of 65% after 15 minutes. Final pathology reports confirmed 5 adenomas and 4 hyperplasias. Our case series reported an incidence of 1.65% (12/728) mediastinal parathyroids, while 1.24% (9/728) received surgical treatment at our institution. Intraoperative frozen section and PTHi are useful to confirm the diagnosis and to avoid recurrences. Although VATS is a safe and efficient treatment option, it depends on surgical training and availability. In terms of diagnostic imaging resources, sestamibi remains the current gold standard. However, 18F-choline PET/CT may arise as a new diagnostic tool. The possibility of obtaining evidence-based conclusions requires studies with higher number of patients.
异位甲状旁腺组织是复发性甲状旁腺功能亢进症(HPT)的常见病因,在原发性HPT中占16%,在继发性病例中占14%。尽管胸内异位腺体占所有异位病例的25%-35%,但仅2%需要胸外科手术。本研究的目的是报告一组在阿根廷一家私立机构接受胸段入路治疗的异位纵隔HPT患者的病例系列。这是一项对2006年1月至2019年6月的回顾性分析。纳入所有诊断为异位甲状旁腺功能亢进症且需要胸段手术入路的患者。在此期间,728例原发性HPT和继发性HPT患者接受了治疗。6例原发性HPT和3例继发性HPT患者需要胸段入路。进行了6例电视辅助胸腔镜手术(VATS)和3例胸骨切开术。他们均未出现严重的术后并发症。所有病例均采用冰冻切片活检。8例患者检测了iPTH,15分钟后平均下降65%。最终病理报告证实5例为腺瘤,4例为增生。我们的病例系列报告纵隔甲状旁腺的发生率为1.65%(12/728),而在我们机构接受手术治疗的比例为1.24%(9/728)。术中冰冻切片和PTHi有助于确诊并避免复发。尽管VATS是一种安全有效的治疗选择,但它取决于手术培训和设备可用性。在诊断成像资源方面, sestamibi仍然是目前的金标准。然而,18F-胆碱PET/CT可能会成为一种新的诊断工具。要得出基于证据的结论,需要对更多患者进行研究。